Journal Article Ppublish 32 citations
PubMed: 39500010 DOI: 10.1016/j.ebiom.2024.105447
The evolving landscape of cardiometabolic diseases.
EBioMedicine 109:105447
Authors: Tolga Eroglu, Federico Capone, Gabriele G Schiattarella
Affiliations
- Max Rubner Center for Cardiovascular Metabolic Renal Research (MRC), Deutsches Herzzentrum der Charité (DHZC), Charité -Universitätsmedizin Berlin, Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.
- Max Rubner Center for Cardiovascular Metabolic Renal Research (MRC), Deutsches Herzzentrum der Charité (DHZC), Charité -Universitätsmedizin Berlin, Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany; Translational Approaches in Heart Failure and Cardiometabolic Disease, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; Department of Medicine (DIMED), Unit of Internal Medicine III, Padua University Hospital, University of Padua, Padova, Italy; Department of Biomedical Sciences, University of Padova, Padova, Italy.
- Max Rubner Center for Cardiovascular Metabolic Renal Research (MRC), Deutsches Herzzentrum der Charité (DHZC), Charité -Universitätsmedizin Berlin, Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany; Translational Approaches in Heart Failure and Cardiometabolic Disease, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
MeSH
Biomedical Research
Cited by
- Effectiveness of different intervention designs for improving physical activity in adults with cardiometabolic conditions over time: a systematic review and network meta-analysis of randomised controlled trials. BMC Med, 2025
- Academic Hegemony and Monitoring of Shared Power in Community-Engaged Research Trials: The Mid-Atlantic Center for Cardiometabolic Health Equity, 2023-2024. Am J Public Health, 2025
- Integrative metabolomics and genomics reveal molecular signatures for type 2 diabetes and its cardiovascular complications. Cardiovasc Diabetol, 2025
- Evaluating the Impact of Family History and Polygenic Risk Scores on Cardiometabolic Disease Risk. Res Sq, 2025